Literature DB >> 3460065

Defective RNA splicing in the absence of adenovirus-associated RNAI.

C Svensson, G Akusjärvi.   

Abstract

We have analyzed late gene expression in 293 cells infected with an adenovirus type 5 mutant dl331, which is defective in production of the low molecular weight virus-associated (VA) RNAI. The results show that several steps in late gene expression are affected. In addition to the previously characterized defect in late mRNA translation, mutant infected cells also show an aberrant selection of RNA splice sites and a substantially reduced L2, L3, and L5 mRNA accumulation. Normal or even slightly elevated amounts of mRNA from region L1 are produced. However, the L1 pre-mRNA is spliced only to generate the mRNA encoding the Mr 52,000-55,000 polypeptide and no detectable mRNA for polypeptide IIIa. Cotransfection of a plasmid encoding VA RNAI complemented the splicing defect in trans, suggesting that the abnormalities are due to the absence of VA RNAI, rather than to a cis-acting change in the nuclear precursor RNA. In a HeLa cell variant, which allows late protein synthesis also in the absence of VA RNAI, because of a lack of eukaryotic initiation factor 2 alpha kinase expression, a normal repertoire of late mRNA was produced. We conclude that a soluble factor, most likely a late viral protein, controls differential RNA splicing and late mRNA accumulation during an adenovirus infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460065      PMCID: PMC323807          DOI: 10.1073/pnas.83.13.4690

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

2.  Adenovirus assay by the fluorescent cell-counting procedure.

Authors:  L PHILIPSON
Journal:  Virology       Date:  1961-11       Impact factor: 3.616

3.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

4.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

5.  Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2.

Authors:  G Akusjärvi; M B Mathews; P Andersson; B Vennström; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Controls of RNA splicing and termination in the major late adenovirus transcription unit.

Authors:  G Akusjärvi; H Persson
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Binding of adenovirus VA RNA to mRNA: a possible role in splicing?

Authors:  M B Mathews
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

8.  Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing.

Authors:  J R Nevins; M C Wilson
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

9.  Ultraviolet transcriptional unit mapping for the late genes in adenovirus type 2.

Authors:  S C Girvitz; A J Rainbow
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

10.  RNA of low molecular weight in KB cells infected with adenovirus type 2.

Authors:  P R Reich; B G Forget; S M Weissman
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

View more
  19 in total

1.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 3.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

Review 5.  Regulation of early adenovirus gene expression.

Authors:  J R Nevins
Journal:  Microbiol Rev       Date:  1987-12

6.  Enhanced splicing of nonconsensus 3' splice sites late during adenovirus infection.

Authors:  O Mühlemann; J P Kreivi; G Akusjärvi
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation.

Authors:  J P Kreivi; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

8.  Expression of functionally active human antithrombin III.

Authors:  A W Stephens; A Siddiqui; C H Hirs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Cis requirements for alternative splicing of the cardiac troponin T pre-mRNA.

Authors:  T A Cooper; M H Cardone; C P Ordahl
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

10.  Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI.

Authors:  S Larsson; C Svensson; G Akusjärvi
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.